The effect of a self-sampling device for human papillomavirus (HPV) test on the women's participation to cervical cancer screening in Italy

Completed

• Conditions: Cervical cancer prevention; Cancer; Malignant neoplasm of the cervix

• Registration Number: ISRCTN96071600
• Lead Sponsor: Centre for Disease Control and Prevention, Italian Ministry of Health (Italy)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-05-18
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 2400

Inclusion Criteria

All women (aged 35 - 64 years) non-responding to the screening invitation in the previous year and eligible for recall

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Performing a test (HPV or Pap) within 3 months since the recall letter.

Secondary Outcome Measures

Name	Time	Method
How many of the women performing a test after the intervention were never-screened or under-screened (last Pap test more than 3 years before)?